DCS Pharma Targets Italian APIs By Acquiring Chemsource And Gopharma
Executive Summary
API specialist DCS Pharma has broken into the “key market” of Italy by acquiring Chemsource and Gopharma.
You may also be interested in...
Cambrex invests in Italian APIs facility
Cambrex is set to invest approximately US$3 million in its Paullo plant in Milan, Italy, to “increase the capacity and efficiency” of the intermediates and active pharmaceutical ingredients (APIs) site.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.